Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBM42 Inhibitors

RBM42 inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBM42, an RNA-binding motif protein involved in post-transcriptional gene regulation. RBM42 plays a crucial role in RNA metabolism, particularly in regulating alternative splicing, mRNA stability, and RNA transport. Like other members of the RNA-binding motif (RBM) family, RBM42 contains RNA recognition motifs (RRMs) that allow it to bind to specific RNA sequences, thereby influencing how RNA is processed and ultimately translated into proteins. This protein is involved in modulating the inclusion or exclusion of exons during splicing, which generates different mRNA isoforms from a single gene, contributing to protein diversity within cells. Inhibitors of RBM42 function by binding to critical regions of the protein, such as its RNA-binding domain, thereby disrupting its interaction with RNA and hindering its regulatory functions in RNA processing.

The inhibition of RBM42 can lead to significant changes in gene expression, particularly in the alternative splicing patterns of key mRNAs. By preventing RBM42 from binding to RNA, these inhibitors disrupt the normal processing of pre-mRNA, which can affect the production of specific protein isoforms crucial for various cellular functions. Researchers use RBM42 inhibitors to investigate the specific role of this protein in splicing regulation and how it contributes to the broader networks of RNA metabolism. These inhibitors are also valuable tools for understanding the mechanisms that control post-transcriptional gene regulation, shedding light on how RNA-binding proteins like RBM42 influence cellular differentiation, growth, and function. Additionally, the study of RBM42 inhibitors provides insights into the broader landscape of RNA-protein interactions and their impact on gene expression. By examining the effects of inhibiting RBM42, researchers can better understand the molecular processes that govern RNA processing and how alterations in these processes contribute to various biological outcomes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Inhibits RNA synthesis by intercalating DNA; thus can suppress the RNA substrates that RBM42 interacts with.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Inhibits BRD4, a protein that may co-localize with RBM42; leads to reduced RNA-binding affinity of RBM42.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

A DNA methyltransferase inhibitor that can modulate gene expression and influence RBM42 mRNA levels.

SGC-CBP30

1613695-14-9sc-473871
sc-473871A
5 mg
10 mg
$178.00
$338.00
(0)

Inhibits CBP/p300 bromodomains, affecting chromatin structure and potentially altering RBM42 RNA binding.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits RNA polymerase II, reducing mRNA transcription rates and thereby affecting RBM42 activity.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II; can reduce the availability of RNA substrates that RBM42 would interact with.

Bleomycin

11056-06-7sc-507293
5 mg
$275.00
5
(0)

Causes RNA cleavage; alters the availability and quality of RNA substrates for RBM42.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

DNA methyltransferase inhibitor that can modulate RBM42 gene expression.

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

Inhibits RNA Pol I, thereby affecting rRNA synthesis, which may influence RBM42 activity.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$265.00
$944.00
5
(1)

P300/CBP inhibitor that may indirectly alter RBM42’s RNA binding affinity by affecting chromatin structure.